Cargando…

Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section

Intravenous (IV) cefuroxime and cefazolin are used prophylactically in caesarean sections (CS). Currently, there are concerns regarding sub-optimal dosing in obese pregnant women compared to lean pregnant women prior to CS. The current study used a physiologically based pharmacokinetic (PBPK) approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alrammaal, Hanadi H., Abduljalil, Khaled, Hodgetts Morton, Victoria, Morris, R. Katie, Marriott, John F., Chong, Hsu P., Batchelor, Hannah K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229966/ https://www.ncbi.nlm.nih.gov/pubmed/35745736 http://dx.doi.org/10.3390/pharmaceutics14061162

Ejemplares similares

Prophylactic perioperative cefuroxime levels in plasma and adipose tissue at the time of caesarean section (C-LACE): a protocol for a pilot experimental, prospective study with non-probability sampling to determine interpatient variability
por: Alrammaal, Hanadi H., et al.
Publicado: (2021)

Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery
por: Asada, Mizuho, et al.
Publicado: (2018)

5% cefuroxime as an alternative to 5% cefazolin in the treatment of Gram-positive bacterial keratitis
por: Chatterjee, Samrat, et al.
Publicado: (2018)

Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention
por: Ahmed, Nehad J., et al.
Publicado: (2022)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations
por: Abduljalil, Khaled, et al.
Publicado: (2022)

Women’s perspectives on caesarean section recovery, infection and the PREPS trial: a qualitative pilot study
por: Weckesser, Annalise, et al.
Publicado: (2019)

Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis
por: Rimmler, Christer, et al.
Publicado: (2019)

Bioequivalence and Population Pharmacokinetic Modeling of Two Forms of Antibiotic, Cefuroxime Lysine and Cefuroxime Sodium, after Intravenous Infusion in Beagle Dogs
por: Zhao, Longshan, et al.
Publicado: (2012)

Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations
por: Ke, Alice Ban, et al.
Publicado: (2018)

Risks of Cefuroxime Prophylaxis for Postcataract Endophthalmitis
por: Al-Abduljabbar, Khaled A., et al.
Publicado: (2017)

Population pharmacokinetic model of cefazolin in total hip arthroplasty
por: Lanoiselée, J., et al.
Publicado: (2021)

The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery
por: Douglas, Alexandra, et al.
Publicado: (2011)

Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics
por: Harun, Siti Norhawani, et al.
Publicado: (2018)

Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients
por: Novak, Alison R, et al.
Publicado: (2021)

Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section
por: Pore, Shraddha M., et al.
Publicado: (2012)

Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients
por: Schmitz, Michael L., et al.
Publicado: (2020)

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery
por: Alli, Ahmad, et al.
Publicado: (2023)

High dose cefuroxime causing retinal toxicity in a patient undergoing trabeculectomy
por: Ku, Jae Yee, et al.
Publicado: (2022)

Plasma Concentrations of Cefazolin in Pediatric Patients Undergoing Cardiac Surgery
por: Lapmahapaisan, Saowaphak, et al.
Publicado: (2021)

Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli
por: Chang, U-Im, et al.
Publicado: (2016)

Cocaine: analysis, pharmacokinetics, and metabolic disposition.
por: Jatlow, P.
Publicado: (1988)

Cefazolin Concentration in the Mediastinal Adipose Tissue of Patients Undergoing Cardiac Surgery
por: Tchaick, Rodrigo Mezzalira, et al.
Publicado: (2017)

Cefuroxime hypersensitivity leading to myocardial ischaemia
por: Tiwari, Rashika, et al.
Publicado: (2022)

Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy
por: van Hasselt, J. G. Coen, et al.
Publicado: (2014)

Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses
por: Kuroda, Taisuke, et al.
Publicado: (2021)

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation
por: Šantavý, Petr, et al.
Publicado: (2022)

Cefuroxime Axetil (Ceftin(®)): A Brief Review
por: Leder, Rachel Deanne, et al.
Publicado: (1997)

Using intracameral cefuroxime as a prophylaxis for endophthalmitis
por: Yorston, David
Publicado: (2008)

Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime
por: Sapino, Simona, et al.
Publicado: (2019)

Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine–Pyrimethamine Disposition Among Ugandan Pregnant Women
por: Odongo, Charles O., et al.
Publicado: (2015)

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”
por: van Hasselt, J. G. Coen, et al.
Publicado: (2015)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

Chlorhexidine vaginal preparation versus standard treatment at caesarean section to reduce endometritis and prevent sepsis—a feasibility study protocol (the PREPS trial)
por: Hodgetts Morton, V., et al.
Publicado: (2018)

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures
por: Depcinski, Shawn C., et al.
Publicado: (2019)

Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime
por: Thorsted, Anders, et al.
Publicado: (2020)

Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability
por: Patel, Yomesh, et al.
Publicado: (2012)

No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia
por: Yayan, Josef, et al.
Publicado: (2015)

The Impact of Antimicrobial Stewardship Program on Injudicious Use of Cefuroxime
por: Arulappen, Ann L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2r5087lffdpisqebv6udb8nti